Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving hepatitis B virus (HBV) cure in the presence or absence of human immunodeficiency virus (HIV).

Deadlines:

  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • AIDS Application Due Date(s): Jan. 7, May 7, Sep. 7

PAS-19-097 Expiration Date January 08, 2022

Agency Website

Amount Description

 

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2019